Samil Pharmaceutical Co.,Ltd (KRX:000520)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,830
+50 (0.46%)
Last updated: Jun 5, 2025

KRX:000520 Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
217,689219,700196,346179,676134,247122,999
Upgrade
Other Revenue
--0--0--0
Upgrade
Revenue
217,689219,700196,346179,676134,247122,999
Upgrade
Revenue Growth (YoY)
6.24%11.89%9.28%33.84%9.14%1.56%
Upgrade
Cost of Revenue
138,102138,785122,275112,19185,25973,967
Upgrade
Gross Profit
79,58780,91474,07167,48648,98849,032
Upgrade
Selling, General & Admin
71,53068,85161,13857,74643,28737,647
Upgrade
Research & Development
7,5456,4105,6012,9072,9713,007
Upgrade
Other Operating Expenses
682.23651.37516.12637.98623.15594.91
Upgrade
Operating Expenses
87,00180,86667,61163,46948,58942,494
Upgrade
Operating Income
-7,41448.116,4604,017399.746,538
Upgrade
Interest Expense
-5,424-5,057-3,545-4,263-6,202-5,505
Upgrade
Interest & Investment Income
67.9962.8434.7270.02129.99164.07
Upgrade
Earnings From Equity Investments
0.440.420.49122.8--
Upgrade
Currency Exchange Gain (Loss)
-673.58-357.06-277.57197.76246.09-155.19
Upgrade
Other Non Operating Income (Expenses)
1,0541,718-2,367580.12299.46183.71
Upgrade
EBT Excluding Unusual Items
-12,389-3,586306.5724.39-5,1271,226
Upgrade
Gain (Loss) on Sale of Investments
---585-7.11--
Upgrade
Gain (Loss) on Sale of Assets
3.16-27.071,702340.82365.84-27.53
Upgrade
Pretax Income
-12,386-3,6131,4241,058-4,7611,198
Upgrade
Income Tax Expense
581.222,016-239.761,086585.31-142.5
Upgrade
Net Income
-12,967-5,6291,664-28.29-5,3471,341
Upgrade
Net Income to Common
-12,967-5,6291,664-28.29-5,3471,341
Upgrade
Net Income Growth
-----70.50%
Upgrade
Shares Outstanding (Basic)
201814141413
Upgrade
Shares Outstanding (Diluted)
201814141413
Upgrade
Shares Change (YoY)
35.65%24.32%3.75%0.82%2.85%0.13%
Upgrade
EPS (Basic)
-661.54-313.00116.16-2.03-386.6399.70
Upgrade
EPS (Diluted)
-661.88-313.00115.00-2.03-386.6399.70
Upgrade
EPS Growth
-----70.28%
Upgrade
Free Cash Flow
-10,635-2,782-12,498-44,327-31,411-9,245
Upgrade
Free Cash Flow Per Share
-542.55-154.68-864.01-3179.28-2271.39-687.53
Upgrade
Dividend Per Share
-----68.182
Upgrade
Gross Margin
36.56%36.83%37.72%37.56%36.49%39.86%
Upgrade
Operating Margin
-3.41%0.02%3.29%2.23%0.30%5.32%
Upgrade
Profit Margin
-5.96%-2.56%0.85%-0.02%-3.98%1.09%
Upgrade
Free Cash Flow Margin
-4.88%-1.27%-6.37%-24.67%-23.40%-7.52%
Upgrade
EBITDA
1,8297,31111,8289,0065,11210,738
Upgrade
EBITDA Margin
0.84%3.33%6.02%5.01%3.81%8.73%
Upgrade
D&A For EBITDA
9,2437,2635,3684,9894,7124,199
Upgrade
EBIT
-7,41448.116,4604,017399.746,538
Upgrade
EBIT Margin
-3.41%0.02%3.29%2.23%0.30%5.32%
Upgrade
Effective Tax Rate
---102.67%--
Upgrade
Advertising Expenses
-8,0698,69911,3897,6746,187
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.